Search results for "Highlights"


 
Results 141 - 150 of about 387 for "Highlights".
Sort by: Relevance | Newest | Oldest

Drug-eluting stents may not confer advantage in diabetic patients

An editorial noted that drug-eluting stents may work for noncomplex lesions in patients with diabetes, but complex disease states incurred high rates of myocardial infarction and revascularization.
https://diabetes.acponline.org/archives/2019/01/11/3.htm
11 Jan 2019

Physician, practice characteristics may affect diabetes care quality

A systematic review and meta-analysis found that physicians who were female, treated diabetes more often, and used electronic health records were associated with higher-quality care in adults with diabetes.
https://diabetes.acponline.org/archives/2020/02/14/1.htm
14 Feb 2020

Cardiovascular event rates similar among newer second-line medications for type 2 diabetes

The comparison of dipeptidyl peptidase-4 inhibitors with other drug classes did find higher rates of major adverse cardiovascular events with basal insulin, sulfonylureas, and meglitinides than with the newer drugs.
https://diabetes.acponline.org/archives/2019/01/11/2.htm
11 Jan 2019

Consensus report updates evidence on managing hyperglycemia in patients with type 2 diabetes

The American Diabetes Association and the European Association for the Study of Diabetes updated their 2018 recommendations based on trials published in 2019.
https://diabetes.acponline.org/archives/2020/01/10/1.htm
10 Jan 2020

SGLT2 inhibitors associated with increased risk of amputations, diabetic ketoacidosis

Sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists had similar rates of other adverse events, including bone fracture, acute kidney injury, serious urinary tract infection, venous thromboembolism, and acute pancreatitis.
https://diabetes.acponline.org/archives/2018/12/14/3.htm
14 Dec 2018

New equation with five variables helps predict hip fracture risk in type 2 diabetes

Age, sex, body mass index, peripheral sensory neuropathy, and estimated glomerular filtration rate were the included variables.
https://diabetes.acponline.org/archives/2018/12/14/2.htm
14 Dec 2018

Incretin-based drugs not associated with any increase in risk for pancreatic diseases

The findings may reassure prescribers of dipeptidyl peptidase-4 inhibitors that the drug class does not significantly increase the risk of adverse pancreatic outcomes compared with other second-line therapies, study authors said.
https://diabetes.acponline.org/archives/2018/11/09/3.htm
9 Nov 2018

Spotlight on depression in diabetes

Recent studies analyzed depression in diabetes, including associated causes of death, the potential benefits of peer support and a plant-based diet, and strategies for screening and treatment.
https://diabetes.acponline.org/archives/2018/11/09/5.htm
9 Nov 2018

No link between vitamin D, omega-3 fatty acid supplements and improved kidney function

An ancillary analysis of the Vitamin D and Omega-3 Trial (VITAL) included 1,312 adult patients with type 2 diabetes who agreed to additional testing of kidney function and urinary albumin excretion at baseline and two and five years after randomization.
https://diabetes.acponline.org/archives/2019/12/13/1.htm
13 Dec 2019

Treatment based on physiologic assessment may help prevent diabetes

In a retrospective observational study, patients with prediabetes were assigned to a risk category for diabetes based on presence and severity of insulin resistance, impaired beta-cell function, and hyperglycemia, then treated accordingly.
https://diabetes.acponline.org/archives/2018/10/12/2.htm
12 Oct 2018

Result Page: Prev   10   11   12   13   14   15   16   17   18   19   Next